Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE ADELE-ARNALSTEEN : revenue, balance sheet and financial ratios

SELARL PHARMACIE ADELE-ARNALSTEEN is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NŒUX-LES-MINES (62290), this company of category PME shows in 2022 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE ADELE-ARNALSTEEN (SIREN 753462894)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 2 671 145 € N/C N/C N/C N/C N/C N/C
Net income 77 540 € 77 857 € 163 688 € 195 795 € 168 744 € 136 172 € 150 521 € 178 409 € 236 245 €
EBITDA N/C N/C 299 670 € N/C N/C N/C N/C N/C N/C
Net margin N/C N/C 6.1% N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE ADELE-ARNALSTEEN generates positive net income of 78 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 236 k€ -> 78 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

77 540 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

31.264%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.611%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

9.6%

Solvency indicators evolution
SELARL PHARMACIE ADELE-ARNALSTEEN

Sector positioning

Debt ratio
31.26 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good -7 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE ADELE-AR... (31.26) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.61% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good

In 2024, the financial autonomy of SELARL PHARMACIE ADELE-AR... (65.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
3.35 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of SELARL PHARMACIE ADELE-AR... (3.35) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 195.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

195.444

Liquidity indicators evolution
SELARL PHARMACIE ADELE-ARNALSTEEN

Sector positioning

Liquidity ratio
195.44 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good -21 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE ADELE-AR... (195.44) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
1.92x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average

In 2022, the interest coverage of SELARL PHARMACIE ADELE-AR... (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE ADELE-ARNALSTEEN

Positioning of SELARL PHARMACIE ADELE-ARNALSTEEN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE ADELE-ARNALSTEEN is estimated at 1 082 515 € (range 753 846€ - 1 619 505€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
753k€ 1082k€ 1619k€
1 082 515 € Range: 753 846€ - 1 619 505€
NAF 5 année 2024

Valuation method used

Net Income Multiple
77 540 € × 14.0x = 1 082 516 €
Range: 753 847€ - 1 619 505€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE ADELE-ARNALSTEEN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE ADELE-ARNALSTEEN

What is the revenue of SELARL PHARMACIE ADELE-ARNALSTEEN ?

The revenue of SELARL PHARMACIE ADELE-ARNALSTEEN in 2022 is 2.7 M€.

Is SELARL PHARMACIE ADELE-ARNALSTEEN profitable?

Yes, SELARL PHARMACIE ADELE-ARNALSTEEN generated a net profit of 78 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE ADELE-ARNALSTEEN ?

The headquarters of SELARL PHARMACIE ADELE-ARNALSTEEN is located in NŒUX-LES-MINES (62290), in the department Pas-de-Calais.

Where to find the tax return of SELARL PHARMACIE ADELE-ARNALSTEEN ?

The tax return of SELARL PHARMACIE ADELE-ARNALSTEEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE ADELE-ARNALSTEEN operate?

SELARL PHARMACIE ADELE-ARNALSTEEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.